Press Releases

All News
By Year:
2019
2018
2017
2016

May 1, 2017

DiaMedica Announces Recently Granted Formulation Patent in U.S. for DM199

Apr 25, 2017

DiaMedica Announces Dr. Nancy Chang to its Strategic Advisory Board

Apr 18, 2017

DiaMedica Therapeutics Completes Private Placement With U.S. Based Family Office

Mar 20, 2017

DiaMedica Announces Issuance of European Composition of Matter Patent and Additional Worldwide Filings for DM199

Mar 13, 2017

DiaMedica Presents Updated Positive DM199 Phase Ib Trial Identifying A Superior Subcutaneous Delivery Profile

Dec 23, 2016

DiaMedica Announces Name Change to DiaMedica Therapeutics Inc.

Dec 20, 2016

DiaMedica Announces Positive Top-Line Results from DM199 Bridging Clinical Trial

Dec 7, 2016

DiaMedica Expands its Business Development Capabilities

Dec 1, 2016

DiaMedica Announces the Sale and Transfer of its DM-71 Product for Type 2 Diabetes

Nov 28, 2016

DiaMedica Inc. Announces Results of Annual General and Special Meeting of Shareholders